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license (http://creativesimilar to cognitive impairment. The identification of biological markers associated with personality
in mild cognitive impairment could advance the early detection of Alzheimer’s disease.
Methods: We used hierarchical multivariate linear models to quantify the interaction between per-
sonality traits, state of cognitive impairment, and MRI biomarkers (gray matter brain volume, gray
matter mean water diffusion) in the medial temporal lobe (MTL).
Results: Over and above a main effect of cognitive state, the multivariate linear model showed sig-
nificant interaction between cognitive state and personality traits predicting MTL abnormality. The
interaction effect was mainly driven by neuroticism and its facets (anxiety, depression, and stress)
and was associated with right-left asymmetry and an anterior to posterior gradient in the MTL.
Discussion: Our results support the hypothesis that personality traits can alter the vulnerability and
pathoplasticity of disease and therefore modulate related biomarker expression.
 2017 The Authors. Published by Elsevier Inc. on behalf of the Alzheimer’s Association. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Keywords: Alzheimer’s disease; Brain; Personality; Neuroimaging; Psychiatry; Prognosis1. Background
Translational research in Alzheimer’s disease (AD) has
relied mostly on tests based on the assessment of cognitive
state to detect individuals at risk, the individuals with mild
cognitive impairment (MCI), and to identify the correspond-
ing disease signatures such as medial temporal lobe (MTL)
atrophy [1–3]. Looking beyond the unidimensional conceptntributed equally to the study.
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he Authors. Published by Elsevier Inc. on behalf of the Alzhe
commons.org/licenses/by-nc-nd/4.0/).of MCI, current research aims to identify other important
risk factors (genetic, personality traits) that would improve
the prognostic accuracy of current tests and explain the
high degree of individual variability in MTL atrophy that
is not associated with cognitive decline.
In AD, personality changes, like cognitive decline, are also
salient features of the disease [2–9]. In previous studies, interest
in personality traits, particularly neuroticism (tendency to
feel negative emotions such as stress, depression) and
conscientiousness (tendency to be self-disciplined), and AD
[10–13] was motivated by the fact that personality traits are
stable into adulthood [14], have genetic-environmental under-
pinnings [15], brain anatomy correlates [16], and are alsoimer’s Association. This is an open access article under the CC BY-NC-ND
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tion [7] or psychiatric symptoms [17]. However, the influence
of personality traits on disease causation and their biological
manifestations still remain unclear [6,8,18].
Our study aims to test whether morbid personality traits
relate to individual differences within the MTL independent
of cognitive state. To further improve the discrimination be-
tween the two groups in term of brain anatomical changes,
we aim to identify the personality profile that minimizes the
variance within each group (MCI and non-cognitively
impaired [NCI]) and maximizes the difference between
them. We predict that neuroticism and its underlying facets,
anxiety, depression, and stress will have the greatest exacer-
bating effects on disease stages. We also expect that identified
personality profile will correlate with known functional orga-
nization within the MTL.
To quantify MTL atrophy, we used structural magnetic
resonance imaging and derived measures of gray matter vol-
ume (GMV) and gray matter mean diffusivity (GMMD).
GMMD is considered a more sensitive marker than GMV
to detect MTL abnormalities in MCI [19]. We used a multi-
variate strategy [20] to provide a comprehensive test of the
association between personality traits, cognitive state, and
brain anatomy. The method (Fig. 1) is data driven, unbiased,
takes into account the multidimensional and hierarchical na-
ture of the five-factor model of personality, and uses anatom-
ical constraints to decompose the different sources of
variability.Fig. 1. (A) NEO Personality inventory (NEO-Pi-R) is hierarchical construct compo
with the hippocampus in yellow and parahippocampal cortex in red. (C) Multiva
distributed pattern that best explain the covariance between personality scores an2. Methods
2.1. Participants
The study included older adults selected from a longitudi-
nal cohort recruited in the psychogeriatric and geriatric
memory clinics of the LausanneUniversity hospital. The local
ethics committee gave permission for the research protocol,
and all participants gave written informed consent before tak-
ing part in the study. All participants completed comprehen-
sive clinical, psychiatric, and cognitive assessments at the
time of MRI scanning. Participants with psychiatric or neuro-
logical central nervous system disorders (stroke, tumor), de-
mentia, and alcohol or drug abuse were excluded. The 97
participants included in the study were divided into two
groups, MCI and NCI, according to the conventional Winblad
criteria [2] where MCI is defined as abnormal but does not
fulfill the diagnostic criteria for dementia. A total of 29 partic-
ipants were MCI (8 males, aged 68 6 8 years, Mini–Mental
State Examination [21] [MMSE]: 27.7 6 1/range [25–29],
Clinical Dementia Rating [22] [CDR] 5 0.5, with MCI am-
nestic 23, nonamnestic 6) and 68 were NCI (18 males, aged
66 6 6 years, MMSE: 29.1 6 1/range [26–30], CDR 5 0).2.2. Personality and neuropsychological/psychiatric
assessments
To obtain reliable measures of current personality pro-
files, we asked relatives of participants to complete thesed of 5 domains and 6 facets for each domain. (B) Search volume of interest
riate Linear Model (MLM) identified the personality profile and the brain
d anatomical measures.
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[23]. This questionnaire, rated on a five-point agreement
scale, is based on the five-factor model of personality
derived from statistical factor analysis of various personal-
ity lexical inventories [23]. It is hierarchically divided into
five broad domains (Fig. 1A): neuroticism (a tendency to
feel negative affects and to be susceptible to psychological
distress), extraversion (a tendency to be sociable and
lively), openness (a tendency to be open to new experi-
ences), agreeableness (a tendency to be cooperative,
altruistic, and trusting), and conscientiousness (a tendency
to be careful, dutiful, and responsible). Each domain
contains six facets (Fig. 1A). The facets of the neuroticism
domain are anxiety, anger, hostility, depression, self-
consciousness, impulsiveness, and vulnerability to stress.
The NEO-PI-R has a high test-retest reliability in the
elderly [23] and high inter-rater reliability in patients
with AD [24].
Internal reliability of NEO-PI-R scores was estimated
with Cronbach’s alpha. In our sample, the values ranged
from 0.63 to 0.68 for the NEO-PI-R domains and from
0.79 to 0.87 for the facets of neuroticism (a nominal value
of 0.7 denotes internal consistency [25]). Other rating
scales and tests used included the Hospital Anxiety and
Depression Scale (HADS-A [anxiety] and HADS-D
[depression], respectively) [26] and the RL-RI-48 memory
item task [27].2.3. Neuroimaging data
Data was acquired using whole-brain MRI T1-weighted
(T1w) structural images (structural magnetic resonance
imaging protocol: 1-mm isotropic resolution with a matrix
of 256!256 voxels, repetition time 2.3 seconds, echo time
2.91 seconds) and diffusion-weighted MRI (1.8!1.8!
2 mm3 resolution, with a matrix of 128!128 voxels, 30 di-
rections, high b-value of 1000 seconds/mm2) on a 3T MRI
scanner (Siemens Trio).
We applied a standard data preprocessing pipeline using a
statistical parametric mapping package [28,29] (SPM8-
Matlab toolbox, www.fil.ion.ucl.ac.uk/spm) to the T1w
images with a bias field correction and unified segmentation
into white and gray matter tissue classes. In addition, we
applied a standard preprocessing pipeline using FreeSurfer
software [30] (FSL; http://www.fmrib.ox.ac.uk/fsl/) with
correction for eddy currents and head movement distortion
before extracting mean diffusion images. Mean diffusion
and T1W images were spatially realigned and normalized
to Montreal Neurological Institute space with the DARTEL
procedure contained in the Voxel-Based Quantification
toolbox [31]. The final outputs were restricted to the graymat-
ter segment to obtain voxel-wise estimations of GMV and
GMMD. Finally, we smoothed the images with an isotropic
gaussian kernel of 8 mm full width at half maximum.
Anatomical labelingwas based on theAutomatedAnatomical
Labeling atlas [32].2.4. Statistical analyses2.4.1. Anatomical differences explained by cognitive state
stratification
We first conducted a univariate regression analysis to test
for differences in the brain measures (GMV and GMMD)
between MCI and NCI groups. The model included the
cognitive state stratification factor, age, and total intracranial
volume as confounding variables.
2.4.2. Anatomical differences explained by personality
domains and cognitive state
Secondly, we used a multivariate model [20] to address
the questionwhether, beyond cognitive factors, there are spe-
cific personality traits that could explain anatomical MTL
differences between MCI and NCI. In the literature, multi-
variate factorial analysis has often been used in studies of
personality to extract significant factorial structures
[23,33,34]. We used a variant of this method, the
multivariate linear method (MLM) that is similar to
standard multivariate factorial analysis but additionally
integrates anatomical information with the cognitive
variables and any confounds. The MLM procedure is based
on singular value decomposition, which summarizes
covariance between personality scores (Fig. 1A) and anatom-
ical data (Fig. 1B). The output of theMLM (Fig. 1C) consists
of pairs of spatially distributed brain patterns associated with
a set of linear combinations of personality traits that are
maximally correlated with them. The significance of the per-
sonality profiles is assessed by amultivariateF-test (based on
partial averages of the eigenvalues) that defines the spaces of
interest for the five personality domains beyond those of the
cognitive and other confounding factors. Post hoc univariate
analyses were then performed with identified profiles to
determine their mapping at the voxel level.
2.4.3. Anatomical differences explained by personality
facets and cognitive state
We performed the MLM analysis at the facet level within
the whole search volume of interest.3. Results
3.1. Demographic, personality traits, and
neuropsychological/psychiatric results
We found (see details in Table 1) no statistical differ-
ences between MCI and NCI groups for all demographic
variables (age, gender). As expected, the MMSE was
significantly different between the two groups, and the
memory scores measured by the RL-RI-48 memory item
task were significantly lower in the MCI group. There
were no statistical differences in HADS-D for depressive
symptoms and HADS-A for anxiety symptoms scores.
Neuroticism scores were also significantly higher in MCI
patients (Table 1).
Table 1
Demographic variables and neuropsychological scores
Non-cognitively impaired
(mean 6 SD) MCI (mean 6 SD)
T- or c2-statistic (d.o.f: degree)T-




MMSE 29.1 6 1 27.7 6 1 5.4 (95) 0
Age 66 6 6 68 6 8 21.6 (95) .1
Gender (Female/Male) 0.7 0.7 0.01 (95) .9
Education level 2 2 0.4 (2) .8
Personality: domain scores (NEO PI-R)
Neuroticism 77.6 6 23 88.8 6 27 22 (95) .04
Extraversion 105.7 6 18 94.72 6 17 2.7 (95) .007
Openness 109.9 6 19 98.9 6 16 2.6 (95) .01
Agreeableness 135.2 6 17 123.2 6 17 3 (95) .003
Conscientiousness 134.5 6 19 111.5 6 22 5 (95) 0
Other neuropsychological scores
Cued recall (RL-RI-48) 29.2 6 4 27.27 240.83 0
Depression score (HADS-D) 2.1 6 2 3.3 6 3 21.8 (95) .07
Anxiety score (HADS-A) 4.7 6 3 5 6 3 20.3 (95) .7
Abbreviations: CDR, Clinical Dementia Rating; HADS, Hospital Anxiety and Depression Scale; MCI, mild cognitive impairment; MMSE, Mini–Mental
State Examination; NEO PI-R, NEO Personality Inventory Revised.
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stratification
Using a whole-brain familywise error correction, we
found no significant differences in GMV. However, with
the same stringent level of correction for multiple compari-
sons, GMMD was significantly different between the two
groups in several regions. In theMTL, localmaxima for these
differences (Table 2) were located in both parahippocampal
and hippocampal subregions (cornu ammonis, dentate gyrus,
and subiculum, according to the probabilistic cytoarchitec-
tonic map [35]). At the whole-brain level, GMMD differ-
ences were significant in the left middle temporal cortex
(Z5 5.06, xyz5 [257,213.5,23]), right superior temporal
cortex (Z 5 4.74, xyz 5 [54,0,23], Z 5 3.83,
xyz 5 [232,223,25]), left insula (Z 5 4.84,
xyz 5 [241,12,214]; Z 5 4.83, xyz 5 [241,3,29]), left
lingual cortex (Z 5 4.65, xyz 5 [212,236,0]), and right
postcentral gyrus (Z5 4.79, xyz5 [53,224,56]). Inclusion
of education level and gender did not add contributive infor-
mation to the brain measures.3.3. Anatomical differences related to personality
domains and cognitive state
Themultivariate analysis of GMV showed that therewas a
significant contribution of personality domains to alterations
in brain structure. The first component identified related to
personality traits (Fig. 2A) was significant (F 5 3.77,
P, e-5) and explained 54.39% of the between-group covari-
ance in the search volume of interest (Fig. 2B). Neuroticism
and agreeableness were identified as the main domains
contributing to this brain component (Fig. 2A). No other re-
gions showed significant differences between the two groups.Post hoc univariate regression analyses of GMV were
performed with the first component of the MLM analysis
as predictor with domain level. This revealed significant
structural differences located in both parahippocampal
cortices (in the entorhinal cortex and subiculum) (Table 2).
The MLM analysis of GMMD also showed a significant
contribution of personality traits (Fig. 2C) to the first
component (F 5 5.32, P , .001), which explained 69.24%
of the between-group covariance in the search volume of in-
terest (Fig. 2D). The neuroticism and agreeableness domains
had moreweight than the three others (Fig. 2C), and a distrib-
uted spatial pattern of brain differences was revealed in the
right hippocampal and parahippocampal cortices (Fig. 2D).
Post hoc univariate analyses of GMMD with the first compo-
nent of the MLM analysis revealed significant brain differ-
ences between MCI and NCI in the subiculum, cornu
ammonis, dentate gyrus, and in a part of the hippocampal-
amygdala transition area (Table 2). Outside this region,
GMMD was also significantly higher in MCI compared
with NCI in the right inferior temporal cortex (at two signif-
icant sites: Z 5 5.77, xyz 5 [39,9,243.5] and Z 5 4.54,
xyz 5 [61.5,231.5,216.5]), the right temporal pole
(Z 5 4.23, xyz 5 [36,18,233]), the right temporal cortex
(at two significant sites: Z 5 4.21, xyz 5 [46.5,251,24.5]
and Z5 4.12, xyz5 [58.5,29,219.5]), and in the right rolan-
dic operculum (Z 5 4.52, xyz 5 [52.5,10,3]).3.4. Anatomical differences related to personality facets of
neuroticism and cognitive state
The MLM analysis of GMV showed contributions from
the neuroticism facets profile (Fig. 2E) in the MTL region,
mainly in the right hemisphere (Fig. 2F). The first
Table 2
Neuroimaging results
Cluster (voxels) Region (label) X Y Z Z statistic
Summary of VBM results
GMMD: MCI . NCI
621 Left hippocampus 214 235 2 4.57
229 227 211 4.27
215 239 5 4.17
217 233 21 4.07
Left parahippocampal 223 236 26 3.72
96 Left parahippocampal 223 7 223 4.26
218 4 220 4.08
1645 Right hippocampus 38 224 27 3.94
30 26 214 3.93
38 28 220 3.85
27 232 23 3.84
17 233 3 3.77
Right parahippocampal cortex 17 235 24 3.31
33 221 224 3.25
112 Right parahippocampal cortex 27 11 223 3.77
Post hoc MLM analysis on the five domains of personality
GMV: interaction with disease: MCI , NCI
209 Left parahippocampal 224 222.5 222.5 3.98
77 Right parahippocampal 24 227 219.5 3.91
24 231.5 213.5 3.74
GMMD: interaction with disease: MCI . NCI
905 Right hippocampus 15 230 23 4.1
Right parahippocampal 22.5 239 23 4.02
28.5 231.5 213.5 3.78
96 Right parahippocampal 30 10.5 231.5 4.07
Right hippocampus 16.5 231.5 1.5 3.86
36 222.5 29 3.8
22.5 231.5 3 3.71
28.5 230 23 3.69
15 227 26 3.5
13.5 234.5 6 3.35
90 Right hippocampus 18 29 213.5 3.79
154 Right hippocampus 30 27.5 212 3.35
28.5 26 221 3.33
Abbreviations: VBM, voxel-based morphometry; GMV, gray matter volume; GMMD, gray matter mean diffusivity; MCI, mild cognitive impairment; MLM,
multivariate linear method.
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72.71% of the covariance (Fig. 2E and F).
The MLM analysis of GMMD again revealed a
significant contribution of the personality facets profile
(Fig. 2G), with the first component significant (F 5 3.52,
P , .0005) and explaining 46.72% of the variance in the
MTL, mainly in the anterior part (Fig. 2H).4. Discussion
Our multifactorial and multivariate analysis decomposes
the complex relationship between three risk markers of AD,
namely (1) anatomical atrophy, (2) cognitive decline, and (3)
personality traits, which together reveal clinical and topo-
graphical signatures in MCI that has direct implications
for refining current models of AD.
Our results are important because, with a few exceptions,
there is a paucity of data-linking personality to neurobiolog-
ical mechanisms of disease. A few neuropathologic studies[8,11,13,36] of confirmed AD cases have provided
evidence for a role of higher levels of neuroticism and
depression in relation to disease symptoms (i.e., a more
rapid cognitive decline in old age and higher risk of AD
[11]) but provide ambiguous evidence for a direct link
with lesions observed at autopsy (no link or linked with a
higher level of neurofibrillary tangles and neuritic plaques)
[8,11,36]. Neuroimaging studies of personality have been
mainly conducted in healthy adults and have found
significant associations between neuroticism trait and
structural differences in frontal and temporal regions [16].
A recent study showed that in MCI individuals, the severity
of white matter lesions in the MTL, but not the atrophy, was
associated with higher neuroticism and lower conscientious-
ness [18]. Here, we investigate the multivariate relationship
between personality and the MTL and provide a link to the
vast majority of AD neuroimaging studies that report consis-
tent effects of stress and depressive symptoms or cognitive
and AD states on the hippocampus [37,38].
Fig. 2. MLM analysis of personality profile at domain level: (A) First Eigen-component (P,0.05) and (B) the associated spatial distribution within the search
volume of interest for GMV; (C) First Eigen-component (P,0.05) and (D) the associated spatial distribution within the search volume of interest for GMMD.
Abbreviations: Neuro, neuroticism; Extra, extraversion; Open, openness; Agree, agreeableness; Consc, conscientiousness. Y axis is an arbitrary unit (AU).
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MCI individuals compared with NCI that extends beyond the
temporal cortex to the left insula, the left lingual cortex, and
the right postcentral gyrus for GMMD. We also observed
that diffusion-based measures are more sensitive than volu-
metric ones to detect brain abnormality in MCI, which is in
line with recent findings [19]. GMMD differences may be
caused by modifications in the intra/extracellular space
due to pre-atrophic changes.
We also identified specific anatomical patterns associated
with personality traits. The MLM analysis of GMMD with
personality domains revealed an asymmetry between the
right and left MTL. The anatomical changes associated
with the facet level of neuroticism showed a spatial
gradient from the anterior to posterior parts of the MTL.
For GMV this asymmetry was also observed at the facetFig. 3. Hypothetical model of state marker in Alzheimer’s disease (AD) including
mality of AD. (A) Vulnerability: Individuals characterized with a different person
onset. (B) Pathoplasticity: Individuals characterized with a different personality p
X axis represents the time, and Y axis, the state biomarker abnormality of AD sulevel of neuroticism. Other studies on the effect of stress
and depression on healthy and depressive individuals have
also reported differences between the left and right hippo-
campal areas that could be explained by neurochemical
and brain tissue property differences [39,40]. The
anteroposterior gradient has been related to the specific
role of the anterior hippocampus in stress and emotion-
related behavior [41]. The link between depression and
AD has also been clinically reported, with chronic distress
and depression being risk factors for cognitive decline in
AD [7,42]. Our results, in light of these studies, converge
to suggest that depression and AD share biological
substrates in the hippocampus that are stress related [43,44].
Our findings highlight neuroticism, agreeableness and
facets of anxiety, stress, hostility, and depression as key
the explanatory variables of anatomical changes in thepersonality trait. The curves show the time evolution of state marker abnor-
ality profile (e.g. with lower neuroticism score) can show different disease
rofile (e.g. with lower neuroticism score) can show different rate of decline.
ch as cognitive or brain decline.
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predictive of cognitive impairment in AD [6,7,11,12]. This
is related to the occurrence of neuropsychiatric problems
(e.g., depression and anxiety symptoms), higher
comorbidity of mental disorders, lower quality of life, and
shorter life expectancy [17,45]. A premorbid agreeableness
is linked to agitation and irritability in AD [4,46]. The low
level of conscientiousness also predicts conversion of MCI
to AD [13]. Although personality traits such as openness
and extraversion [4,5] have been associated with early AD
and MCI, we found less effect of these domains in our
study. This can be due to fact that in our study, we
identified the personality traits that correlate with brain
changes and not just cognition stratification.
Our data suggest that personality is an important
parameter that needs to be included in the modeling of
the pathophysiological processes leading to AD [7,47].
Recently, a new model has been proposed by Jack et al.
(2013) [47] in which different states of the AD
biomarkers (e.g., brain atrophy, tau, amyloid b, memory,
and clinical function) each follow a sigmoid-shaped
curve. The authors argue that for AD model, the most
informative parameters are the onsets of curves on the hor-
izontal time axis, their slopes, and their temporal ordering.
We suggest adding another level to this model based on the
psychopathology literature, whereby a specific personal-
ity trait, such as proneness to stress or depression, can
affect the shape and the temporal ordering of biomarker
state curves by two main mechanisms (Fig. 3). The first
mechanism is predisposition/vulnerability, where a
certain personality trait profile modulates the risk of dis-
ease and changes the onset of biomarker curves. The sec-
ond exacerbating mechanism is pathoplasticity, where a
personality trait has an additive (or diminishing) effect
on the course of disease and hence impacts the slopes of
the temporal curves.
Therefore, other features, such as behavioral and
psychological symptoms [45], pathophysiological markers
of AD, genetic susceptibility factors such as serotonin
[48,49], and personality, as demonstrated here and
elsewhere, may help to clarify mechanisms to explain the
associations between cognitive decline and MTL atrophy
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1. Systematic review:Most prior studies have focused on
personality changes after Alzheimer’s disease onset.
Fewer studies reported associations between postmor-
tempathologicalmarkers and personality traits. Ama-
jority of studies examined the effect of one or two
traits separately to dementia incidence and also re-
ported significant contribution of neuroticism.
2. Interpretation: We found a specific association be-
tween cognitive decline, personality traits, and
biological changes in the medial temporal lobe.
Interestingly, from disease modeling point of view,
the association was explained by a low-dimensional
factor, which corresponded to a personality profile
dominated by neuroticism trait associated with a
spatial gradient along the medial temporal lobe.
3. Future directions: These findings add to the body of
evidence that personality traits are stable features,
which in the context of cognitive decline, lead to
brain vulnerability. Multifactorial models, as pro-
posed here, are needed to combine the different states
and trait markers for accurate Alzheimer’s disease
risk prediction.
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